 | • レポートコード：QYR9N7468 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、QT延長症候群の治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・QT延長症候群の治療の世界市場規模 ・主要企業別市場シェア ・QT延長症候群の治療の世界市場規模：種類別（薬、手術療法） ・QT延長症候群の治療の世界市場規模：用途別（病院、診療所、その他） ・QT延長症候群の治療のアメリカ市場規模（種類別、用途別） ・QT延長症候群の治療のヨーロッパ市場規模（種類別、用途別） ・QT延長症候群の治療の中国市場規模（種類別、用途別） ・QT延長症候群の治療の日本市場規模（種類別、用途別） ・QT延長症候群の治療の東南アジア市場規模（種類別、用途別） ・QT延長症候群の治療のインド市場規模（種類別、用途別） ・QT延長症候群の治療の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・QT延長症候群の治療の世界市場予測（2019年-2025年） ・QT延長症候群の治療の地域別市場予測（2019年-2025年） ... |
Long QT syndrome is a condition which affects repolarization of the heart after a heartbeat. This results in an increased risk of an irregular heartbeat which can result in palpitations, fainting, drowning, or sudden death. These episodes can be triggered by exercise or stress. Other associated symptoms may include hearing loss.In 2018, the global Long QT Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Long QT Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Long QT Syndrome Treatment development in United States, Europe and China.
The key players covered in this study
Boston Scientific
Cadila Healthcare
Pfizer
AstraZeneca
Lupin Pharmaceuticals
Cipla
Mylan
Teva Pharmaceutical
Old API Wind-Down
Torrent Pharmaceuticals
Market segment by Type, the product can be split into
Medication
Surgery Therapy
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Long QT Syndrome Treatment status, future forecast, growth opportunity, key market and key players.
To present the Long QT Syndrome Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Long QT Syndrome Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Long QT Syndrome Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Medication
1.4.3 Surgery Therapy
1.5 Market by Application
1.5.1 Global Long QT Syndrome Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Long QT Syndrome Treatment Market Size
2.2 Long QT Syndrome Treatment Growth Trends by Regions
2.2.1 Long QT Syndrome Treatment Market Size by Regions (2014-2025)
2.2.2 Long QT Syndrome Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Long QT Syndrome Treatment Market Size by Manufacturers
3.1.1 Global Long QT Syndrome Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Long QT Syndrome Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Long QT Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Long QT Syndrome Treatment Key Players Head office and Area Served
3.3 Key Players Long QT Syndrome Treatment Product/Solution/Service
3.4 Date of Enter into Long QT Syndrome Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Long QT Syndrome Treatment Market Size by Type (2014-2019)
4.2 Global Long QT Syndrome Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Long QT Syndrome Treatment Market Size (2014-2019)
5.2 Long QT Syndrome Treatment Key Players in United States
5.3 United States Long QT Syndrome Treatment Market Size by Type
5.4 United States Long QT Syndrome Treatment Market Size by Application
6 Europe
6.1 Europe Long QT Syndrome Treatment Market Size (2014-2019)
6.2 Long QT Syndrome Treatment Key Players in Europe
6.3 Europe Long QT Syndrome Treatment Market Size by Type
6.4 Europe Long QT Syndrome Treatment Market Size by Application
7 China
7.1 China Long QT Syndrome Treatment Market Size (2014-2019)
7.2 Long QT Syndrome Treatment Key Players in China
7.3 China Long QT Syndrome Treatment Market Size by Type
7.4 China Long QT Syndrome Treatment Market Size by Application
8 Japan
8.1 Japan Long QT Syndrome Treatment Market Size (2014-2019)
8.2 Long QT Syndrome Treatment Key Players in Japan
8.3 Japan Long QT Syndrome Treatment Market Size by Type
8.4 Japan Long QT Syndrome Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Long QT Syndrome Treatment Market Size (2014-2019)
9.2 Long QT Syndrome Treatment Key Players in Southeast Asia
9.3 Southeast Asia Long QT Syndrome Treatment Market Size by Type
9.4 Southeast Asia Long QT Syndrome Treatment Market Size by Application
10 India
10.1 India Long QT Syndrome Treatment Market Size (2014-2019)
10.2 Long QT Syndrome Treatment Key Players in India
10.3 India Long QT Syndrome Treatment Market Size by Type
10.4 India Long QT Syndrome Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Long QT Syndrome Treatment Market Size (2014-2019)
11.2 Long QT Syndrome Treatment Key Players in Central & South America
11.3 Central & South America Long QT Syndrome Treatment Market Size by Type
11.4 Central & South America Long QT Syndrome Treatment Market Size by Application
12 International Players Profiles
12.1 Boston Scientific
12.1.1 Boston Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Long QT Syndrome Treatment Introduction
12.1.4 Boston Scientific Revenue in Long QT Syndrome Treatment Business (2014-2019)
12.1.5 Boston Scientific Recent Development
12.2 Cadila Healthcare
12.2.1 Cadila Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Long QT Syndrome Treatment Introduction
12.2.4 Cadila Healthcare Revenue in Long QT Syndrome Treatment Business (2014-2019)
12.2.5 Cadila Healthcare Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Long QT Syndrome Treatment Introduction
12.3.4 Pfizer Revenue in Long QT Syndrome Treatment Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Long QT Syndrome Treatment Introduction
12.4.4 AstraZeneca Revenue in Long QT Syndrome Treatment Business (2014-2019)
12.4.5 AstraZeneca Recent Development
12.5 Lupin Pharmaceuticals
12.5.1 Lupin Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Long QT Syndrome Treatment Introduction
12.5.4 Lupin Pharmaceuticals Revenue in Long QT Syndrome Treatment Business (2014-2019)
12.5.5 Lupin Pharmaceuticals Recent Development
12.6 Cipla
12.6.1 Cipla Company Details
12.6.2 Company Description and Business Overview
12.6.3 Long QT Syndrome Treatment Introduction
12.6.4 Cipla Revenue in Long QT Syndrome Treatment Business (2014-2019)
12.6.5 Cipla Recent Development
12.7 Mylan
12.7.1 Mylan Company Details
12.7.2 Company Description and Business Overview
12.7.3 Long QT Syndrome Treatment Introduction
12.7.4 Mylan Revenue in Long QT Syndrome Treatment Business (2014-2019)
12.7.5 Mylan Recent Development
12.8 Teva Pharmaceutical
12.8.1 Teva Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Long QT Syndrome Treatment Introduction
12.8.4 Teva Pharmaceutical Revenue in Long QT Syndrome Treatment Business (2014-2019)
12.8.5 Teva Pharmaceutical Recent Development
12.9 Old API Wind-Down
12.9.1 Old API Wind-Down Company Details
12.9.2 Company Description and Business Overview
12.9.3 Long QT Syndrome Treatment Introduction
12.9.4 Old API Wind-Down Revenue in Long QT Syndrome Treatment Business (2014-2019)
12.9.5 Old API Wind-Down Recent Development
12.10 Torrent Pharmaceuticals
12.10.1 Torrent Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Long QT Syndrome Treatment Introduction
12.10.4 Torrent Pharmaceuticals Revenue in Long QT Syndrome Treatment Business (2014-2019)
12.10.5 Torrent Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Long QT Syndrome Treatment Key Market Segments
Table Key Players Long QT Syndrome Treatment Covered
Table Global Long QT Syndrome Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Long QT Syndrome Treatment Market Size Market Share by Type 2014-2025
Figure Medication Figures
Table Key Players of Medication
Figure Surgery Therapy Figures
Table Key Players of Surgery Therapy
Table Global Long QT Syndrome Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Long QT Syndrome Treatment Report Years Considered
Table Global Long QT Syndrome Treatment Market Size 2014-2025 (Million US$)
Figure Global Long QT Syndrome Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Long QT Syndrome Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Long QT Syndrome Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Long QT Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Long QT Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Long QT Syndrome Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Long QT Syndrome Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Long QT Syndrome Treatment Market Share by Manufacturers (2014-2019)
Figure Global Long QT Syndrome Treatment Market Share by Manufacturers in 2018
Table Global Long QT Syndrome Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Long QT Syndrome Treatment Product/Solution/Service
Table Date of Enter into Long QT Syndrome Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Long QT Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Long QT Syndrome Treatment Market Size Share by Type (2014-2019)
Figure Global Long QT Syndrome Treatment Market Size Market Share by Type (2014-2019)
Table Global Long QT Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Long QT Syndrome Treatment Market Size Share by Application (2014-2019)
Figure Global Long QT Syndrome Treatment Market Size Market Share by Application (2014-2019)
Figure Global Long QT Syndrome Treatment Revenue Market Share by Application in 2018
Figure United States Long QT Syndrome Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Long QT Syndrome Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Long QT Syndrome Treatment Market Share (2018-2019)
Table United States Long QT Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Long QT Syndrome Treatment Market Share by Type (2014-2019)
Table United States Long QT Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Long QT Syndrome Treatment Market Share by Application (2014-2019)
Figure Europe Long QT Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Long QT Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Long QT Syndrome Treatment Market Share (2018-2019)
Table Europe Long QT Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Long QT Syndrome Treatment Market Share by Type (2014-2019)
Table Europe Long QT Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Long QT Syndrome Treatment Market Share by Application (2014-2019)
Figure China Long QT Syndrome Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Long QT Syndrome Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Long QT Syndrome Treatment Market Share (2018-2019)
Table China Long QT Syndrome Treatment Market Size by Type (2014-20189) (Million US$)
Table China Long QT Syndrome Treatment Market Share by Type (2014-2019)
Table China Long QT Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table China Long QT Syndrome Treatment Market Share by Application (2014-2019)
Figure Japan Long QT Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Long QT Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Long QT Syndrome Treatment Market Share (2018-2019)
Table Japan Long QT Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Long QT Syndrome Treatment Market Share by Type (2014-2019)
Table Japan Long QT Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Long QT Syndrome Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Long QT Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Long QT Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Long QT Syndrome Treatment Market Share (2018-2019)
Table Southeast Asia Long QT Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Long QT Syndrome Treatment Market Share by Type (2014-2019)
Table Southeast Asia Long QT Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Long QT Syndrome Treatment Market Share by Application (2014-2019)
Figure India Long QT Syndrome Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Long QT Syndrome Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Long QT Syndrome Treatment Market Share (2018-2019)
Table India Long QT Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table India Long QT Syndrome Treatment Market Share by Type (2014-2019)
Table India Long QT Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table India Long QT Syndrome Treatment Market Share by Application (2014-2019)
Figure Central & South America Long QT Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Long QT Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Long QT Syndrome Treatment Market Share (2018-2019)
Table Central & South America Long QT Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Long QT Syndrome Treatment Market Share by Type (2014-2019)
Table Central & South America Long QT Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Long QT Syndrome Treatment Market Share by Application (2014-2019)
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Long QT Syndrome Treatment Business (2014-2019) (Million US$)
Figure Boston Scientific Revenue Growth Rate in Long QT Syndrome Treatment Business (2014-2019)
Table Boston Scientific Recent Development
Table Cadila Healthcare Company Details
Table Cadila Healthcare Revenue in Long QT Syndrome Treatment Business (2014-2019)(Million US$)
Figure Cadila Healthcare Revenue Growth Rate in Long QT Syndrome Treatment Business (2014-2019)
Table Cadila Healthcare Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Long QT Syndrome Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Long QT Syndrome Treatment Business (2014-2019)
Table Pfizer Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Long QT Syndrome Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Long QT Syndrome Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Lupin Pharmaceuticals Company Details
Table Lupin Pharmaceuticals Revenue in Long QT Syndrome Treatment Business (2014-2019)(Million US$)
Figure Lupin Pharmaceuticals Revenue Growth Rate in Long QT Syndrome Treatment Business (2014-2019)
Table Lupin Pharmaceuticals Recent Development
Table Cipla Company Details
Table Cipla Revenue in Long QT Syndrome Treatment Business (2014-2019)(Million US$)
Figure Cipla Revenue Growth Rate in Long QT Syndrome Treatment Business (2014-2019)
Table Cipla Recent Development
Table Mylan Company Details
Table Mylan Revenue in Long QT Syndrome Treatment Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Long QT Syndrome Treatment Business (2014-2019)
Table Mylan Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Long QT Syndrome Treatment Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Long QT Syndrome Treatment Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Old API Wind-Down Company Details
Table Old API Wind-Down Revenue in Long QT Syndrome Treatment Business (2014-2019)(Million US$)
Figure Old API Wind-Down Revenue Growth Rate in Long QT Syndrome Treatment Business (2014-2019)
Table Old API Wind-Down Recent Development
Table Torrent Pharmaceuticals Company Details
Table Torrent Pharmaceuticals Revenue in Long QT Syndrome Treatment Business (2014-2019)(Million US$)
Figure Torrent Pharmaceuticals Revenue Growth Rate in Long QT Syndrome Treatment Business (2014-2019)
Table Torrent Pharmaceuticals Recent Development
Table Global Long QT Syndrome Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Long QT Syndrome Treatment Market Size Share by Regions (2019-2025)
Figure Global Long QT Syndrome Treatment Market Size Share by Regions in 2025
Figure United States Long QT Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Long QT Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Long QT Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Long QT Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Long QT Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Long QT Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Long QT Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Long QT Syndrome Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Long QT Syndrome Treatment Market Size by Product (2019-2025)
Figure Global Long QT Syndrome Treatment Market Size by Product in 2025
Table Global Long QT Syndrome Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Long QT Syndrome Treatment Market Size by Application (2019-2025)
Figure Global Long QT Syndrome Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のスタージウェーバー症候群（SWS）治療市場：市場規模・現状・予測 Sturge-Weber syndrome or Sturge-Weber-Krabbe disease, sometimes referred to as encephalotrigeminal angiomatosis, is a rare congenital neurological and skin disorder. It is one of the phakomatoses and is often associated with port-wine stains of the face, glaucoma, seizures, mental retardation, and i…- 世界の腫瘍随伴症候群の治療市場：市場規模・現状・予測 A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically see…
- 世界の胸郭出口症候群市場：市場規模・現状・予測 Thoracic outlet syndrome is a group of heterogeneous and disabling upper-extremity disorders that occur due to extrinsic compression of neurovascular structures between the clavicle and the first rib. There are three distinct types of thoracic outlet syndrome viz. neurogenic thoracic outlet syndrome…
- 世界のクリッペルトレノーネー症候群の治療市場：市場規模・現状・予測 Klippel–Trenaunay Syndrome (KTS or KT) is a rare congenital medical condition in which blood vessels and/or lymph vessels fail to form properly. The three main features are nevus flammeus (port-wine stain), venous and lymphatic malformations, and soft-tissue hypertrophy of the affected limb. It is s…
- 世界のリウマチ性腫瘍随伴症候群の治療市場：市場規模・現状・予測 A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically see…